Novo Nordisk Faces Crosswinds: EU Approvals and Heart Data Offset Brazil Generic Threat and Pricing
Novo Nordisk stock near €38 as Brazil OKs generic Ozempic, EU clears 2 Wegovy variants, CV study shows…
Novo Nordisk Faces Two Realities: EU Approvals Bolster Pipeline as Canadian Patent Loss and Pricing
Novo Nordisk secures EU backing for oral and high-dose Wegovy but faces Canadian patent loss on Ozempic, triggering…
Novo Nordisk Taps European Approvals and a Gulf Hub as US Price Pressure Persists
Novo Nordisk gains EU endorsements for oral and high-dose Wegovy, plans MASH data, and builds a UAE logistics…
Greenland Approvals and a $24 Million Cash Gap Test the Rally
European Lithium stock rallies 205% YTD, but merger with Critical Metals faces A$24M cash shortfall and exclusivity ban…
Berlin HDC approves completed hotel work | News
(Feb. 13, 2026) Improvements at Berlin’s Atlantic Hotel were approved after the fact by the Historic District Commission…